Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Correction: The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders
    Published on 2026-03-12
    5 months ago
  • Continued progress and innovation at Neuropsychopharmacology (NPP)
    Published on 2026-03-08
    5 months ago
  • Exposome and mental health across the lifespan: research and clinical perspectives
    Published on 2026-03-08
    5 months ago
  • Triazole 187 is a biased KOR agonist that suppresses itch without sedation and induces anxiolytic-like behaviors in mice
    Published on 2026-03-08
    5 months ago
  • Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds
    Published on 2026-03-06
    5 months ago
  • Investigational drugs in PTSD
    Published on 2026-03-05
    5 months ago
  • Sex-specific neural activation to stress and alcohol cues in high-risk drinkers: links between orbitofrontal circuits, alcohol craving, and future drinking
    Published on 2026-03-05
    5 months ago
« Previous 1 … 17 18 19 20 21 … 143 Next »
Journal of Psychopharmacology
  • Facing trauma under the influence of psychedelics: A phenomenological study with Nova rave survivors
    Published on 2025-11-11
    9 months ago
  • Effects of a Scutellaria baicalensis/Crataegus laevigata, magnesium and chromium supplement on stressed individuals: A randomised, double-blind, placebo-controlled, crossover trial
    Published on 2025-11-06
    9 months ago
  • Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
    Published on 2025-11-04
    9 months ago
  • The effects of naturalistic cannabis use on cognition and subjective experience in older adults with normal cognitive function
    Published on 2025-11-03
    9 months ago
  • A one-compartment model provides benchmark Lithium dose prediction
    Published on 2025-10-30
    9 months ago
  • The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia
    Published on 2025-10-29
    9 months ago
  • Pharmacological effects on 35% CO2 panic induction: A meta-analysis
    Published on 2025-10-29
    9 months ago
« Previous 1 … 17 18 19 20 21 … 150 Next »
European Neuropsychopharmacology
  • Is psychosis an obstetric condition? Revisiting the role of early-life environmentally stressful events
    Published on 2025-10-26
    9 months ago
  • Toward rigorous control conditions in trials of digital therapeutics
    Published on 2025-10-26
    9 months ago
  • Editorial Board
    Published on 2025-10-17
    9 months ago
  • Structural connectomic signatures of childhood maltreatment across affective and psychotic disorders
    Published on 2025-10-14
    10 months ago
  • Response to Commentaries on Article: “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”
    Published on 2025-09-23
    10 months ago
  • Machine learning and neuroimaging in mood disorders: A promising path forward
    Published on 2025-09-23
    10 months ago
  • Comment on “Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction”
    Published on 2025-09-23
    10 months ago
« Previous 1 … 17 18 19 20 21 … 168 Next »

   Pharma Pub